Risk factors for fluconazole-resistant Candida glabrata Bloodstream infections
Academic Article
Overview
MeSH Major
Antifungal Agents
Candida glabrata
Drug Resistance, Fungal
Fluconazole
Fungemia
abstract
Previous fluconazole use is a significant risk factor for health care-associated fluconazole-resistant C glabrata BSIs. Future studies will be needed to evaluate the effect of decreasing fluconazole use on rates of fluconazole-resistant C glabrata BSIs.